Alamar Biosciences, Inc. (ALMR) vs Aveanna Healthcare Holdings Inc. (AVAH)
A side-by-side comparison of Alamar Biosciences, Inc. and Aveanna Healthcare Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMR
Alamar Biosciences, Inc.
$38.13HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
AVAH
Aveanna Healthcare Holdings Inc.
$12.37HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALMR vs AVAH
growth of $100 · dividends reinvested · last 1yALMR +73.3% (+73.3%/yr)AVAH +82.7% (+82.7%/yr)AVAH compounded faster over this window
ALMR AVAH
ALMR vs AVAH: by the numbers
- •AVAH is the larger company ($2.69B vs $2.64B market cap).
- •AVAH is profitable (10.56% net margin) while ALMR runs a net loss (-40.18%).
Metrics side by side
Valuation
| Metric | ALMR | AVAH |
|---|---|---|
| P/E ratio | N/A | 9.79 |
| Forward P/E | N/A | 15.02 |
| P/S ratio | N/A | 1.03 |
| P/B ratio | 8.45 | 9.38 |
| EV / EBITDA | N/A | 13.24 |
| FCF yield | N/A | 5.88% |
Profitability
| Metric | ALMR | AVAH |
|---|---|---|
| Gross margin | 56.20% | 31.95% |
| Operating margin | -42.22% | 11.12% |
| Net margin | -40.18% | 10.56% |
| ROE | N/A | 95.64% |
| ROIC | -26.95% | 15.45% |
Growth (annualized)
| Metric | ALMR | AVAH |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.65% |
| FCF CAGR (5Y) | N/A | 58.99% |
| Total return CAGR (5Y) | N/A | 9.75% |
Frequently asked
- Is ALMR or AVAH more profitable?
- AVAH runs the higher net margin — ALMR at -40.18% versus AVAH at 10.56%.
Go deeper
Dig into the metrics
Aveanna Healthcare P/E ratioAlamar Biosciences ROEAveanna Healthcare ROEAlamar Biosciences operating marginAveanna Healthcare operating marginAlamar Biosciences revenue growthAveanna Healthcare revenue growthAlamar Biosciences free cash flowAveanna Healthcare free cash flow
Alamar Biosciences & Aveanna Healthcare appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.